Laura Nisenbaum

Laura Nisenbaum is the interim chief science officer at the Alzheimer’s Drug Discovery Foundation, where she focuses on advancing research into Alzheimer’s disease and dementia prevention. Recently, she was in the news for discussing the potential of lifestyle interventions to reduce the risk of dementia, emphasizing that up to 45% of dementia cases might be preventable through exercise, diet, and social engagement.